Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intepirdine in Dementia with Lewy Bodies
NCT02669433Phase 2Completed
- Sponsor
- Sio Gene Therapies
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of intepirdine in dementia with Lewy bodies (DLB), sponsored by Sio Gene Therapies. Started Jan 2016; status: completed.
02
Drugs
intepirdine
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT02669433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669433.